Hong Kong stock market anomaly | Shengnuo Medicine-B (02257.HK) rose more than 5% in the afternoon. Huaxi Biological subscribes to the company's shares, focusing on the STP705 targeted fat reduction project.

According to the Securities Times app, Sanofi Medicine-B (02257.HK) surged more than 5% in the afternoon, with a 3.62% increase as of the time of publication, reaching 19.46 Hong Kong dollars, with a turnover of 32.4354 million Hong Kong dollars.